UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Identification of 28 novel mutations in the Bardet-Biedl syndrome genes: the burden of private mutations in an extensively heterogeneous disease

Human genetics, 2010-05, Vol.127 (5), p.583-593

2010

Volltextzugriff (PDF)

Confirmation of TFAP2A gene involvement in branchio-oculo-facial syndrome (BOFS) and report of temporal bone anomalies

American journal of medical genetics. Part A, 2009-10, Vol.149A (10), p.2141-2146

2009

Volltextzugriff (PDF)

The locations of the H-twist and H-dermo-1 genes are distinct on the human genome

Biochimica et biophysica acta, 1997-02, Vol.1360 (1), p.1-2

1997

Volltextzugriff (PDF)

Potassium channel blocking actions of dendrotoxins

Toxicon (Oxford), 1996-03, Vol.34 (3), p.288-288

1996

Volltextzugriff (PDF)

In vitro activation of DNA polymerase-α by a protein kinase in chick embryo

FEBS letters, 1981-02, Vol.124 (1), p.84-88

1981

Volltextzugriff (PDF)

Molecular Evolution of Snake Toxins: Is the Functional Diversity of Snake Toxins Associated with a Mechanism of Accelerated Evolution?

Progress in Nucleic Acid Research and Molecular Biology, 1997, Vol.59, p.307-364

1997

Volltextzugriff (PDF)

First Report of 3-Year Clinical Outcome After Treatment With Novel Resolute Onyx Stents in the Randomized BIONYX Trial

Circulation Journal, 2021/10/25, Vol.85(11), pp.1983-1990

2021

Volltextzugriff (PDF)

Thin composite wire strut, durable polymer-coated (Resolute Onyx) versus ultrathin cobalt–chromium strut, bioresorbable polymer-coated (Orsiro) drug-eluting stents in allcomers with coronary artery disease (BIONYX): an international, single-blind, randomised non-inferiority trial

The Lancet (British edition), 2018-10, Vol.392 (10154), p.1235-1245

2018

Volltextzugriff (PDF)

Thin Composite-Wire-Strut Zotarolimus-Eluting Stents Versus Ultrathin-Strut Sirolimus-Eluting Stents in BIONYX at 2 Years

JACC. Cardiovascular interventions, 2020-05, Vol.13 (9), p.1100-1109

2020

Volltextzugriff (PDF)

Thin, Very Thin, or Ultrathin Strut Biodegradable or Durable Polymer-Coated Drug-Eluting Stents

JACC. Cardiovascular interventions, 2019-09, Vol.12 (17), p.1650-1660

2019

Volltextzugriff (PDF)

Prediabetes and its impact on clinical outcome after coronary intervention in a broad patient population

EuroIntervention, 2018-10, Vol.14 (9), p.e1049-e1056

2018

Volltextzugriff (PDF)

Thin, Very Thin, or Ultrathin Strut Biodegradable or Durable Polymer-Coated Drug-Eluting Stents: 3-Year Outcomes of BIO-RESORT

JACC. Cardiovascular interventions, 2019-09, Vol.12 (17), p.1650-1660

2019

Volltextzugriff (PDF)

Impact of prediabetes and diabetes on 3-year outcome of patients treated with new-generation drug-eluting stents in two large-scale randomized clinical trials

Cardiovascular diabetology, 2021-10, Vol.20 (1), p.217-217, Article 217

2021

Volltextzugriff (PDF)

Outcome after percutaneous coronary intervention with contemporary stents in patients with concomitant peripheral arterial disease: A patient-level pooled analysis of four randomized trials

Atherosclerosis, 2022-08, Vol.355, p.52-59

2022

Volltextzugriff (PDF)

Final 5‐year report of BIONYX comparing the thin‐composite wire‐strut zotarolimus‐eluting stent versus ultrathin‐strut sirolimus‐eluting stent

Catheterization and cardiovascular interventions, 2024-07, Vol.104 (1), p.1-9

2024

Volltextzugriff (PDF)

Small-vessel treatment with contemporary newer-generation drug-eluting coronary stents in all-comers: Insights from 2-year DUTCH PEERS (TWENTE II) randomized trial

The American heart journal, 2016-06, Vol.176, p.28-35

2016

Volltextzugriff (PDF)

Final 5-Year Report of the Randomized BIO-RESORT Trial Comparing 3 Contemporary Drug-Eluting Stents in All-Comers

Journal of the American Heart Association, 2022-11, Vol.11 (22), p.e026041-e026041

2022

Volltextzugriff (PDF)

Risk of bleeding after percutaneous coronary intervention and its impact on further adverse events in clinical trial participants with comorbid peripheral arterial disease

International journal of cardiology, 2023-03, Vol.374, p.27-32

2023

Volltextzugriff (PDF)

Two-year clinical outcome of all-comers treated with three highly dissimilar contemporary coronary drug-eluting stents in the randomised BIO-RESORT trial

EuroIntervention, 2018-10, Vol.14 (8), p.915-923

2018

Volltextzugriff (PDF)

TCT-518 Final 5-Year Report of the Randomized BIONYX Trial Assessing Onyx Versus Orsiro Drug-eluting Stents in All-Comers

Journal of the American College of Cardiology, 2023-10, Vol.82 (17), p.B209-B210

2023

Volltextzugriff (PDF)

Two-year outcome after treatment of severely calcified lesions with newer-generation drug-eluting stents in acute coronary syndromes: A patient-level pooled analysis from TWENTE and DUTCH PEERS

Journal of cardiology, 2017-04, Vol.69 (4), p.660-665

2017

Volltextzugriff (PDF)

5-Year Outcome Following Randomized Treatment of All-Comers With Zotarolimus-Eluting Resolute Integrity and Everolimus-Eluting PROMUS Element Coronary Stents: Final Report of the DUTCH PEERS (TWENTE II) Trial

JACC. Cardiovascular interventions, 2018-03, Vol.11 (5), p.462-469

2018

Volltextzugriff (PDF)

Three contemporary thin‐strut drug‐eluting stents implanted in severely calcified coronary lesions of participants in a randomized all‐comers trial

Catheterization and cardiovascular interventions, 2020-11, Vol.96 (5), p.E508-E515

2020

Volltextzugriff (PDF)

1 – 25 von 60

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(56)
Mit Volltextzugriff
(52)

Publikationsform

Artikel
(59)
Buchkapitel
(1)

Sprache

Englisch
(59)
Spanisch
(1)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(43)
Science & Technology
(43)
Percutaneous Coronary Intervention
(37)
Cardiac & Cardiovascular Systems
(34)
Cardiovascular System & Cardiology
(34)
Humans
(27)
Drug-Eluting Stents
(22)
Female
(18)
Male
(18)
Aged
(17)
Middle Aged
(16)
Patients
(14)
Stents
(14)
Treatment Outcome
(14)
Drug-Eluting Stent
(13)
Coronary Artery Disease
(12)
Myocardial Infarction
(12)
Percutaneous Coronary Intervention - Adverse Effects
(12)
Percutaneous Coronary Intervention - Instrumentation
(11)
Polymers
(11)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Identification of 28 novel mutations in the Bardet-Biedl syndrome genes: the burden of private mutations in an extensively heterogeneous disease

Confirmation of TFAP2A gene involvement in branchio-oculo-facial syndrome (BOFS) and report of temporal bone anomalies

The locations of the H-twist and H-dermo-1 genes are distinct on the human genome

Potassium channel blocking actions of dendrotoxins

In vitro activation of DNA polymerase-α by a protein kinase in chick embryo

Molecular Evolution of Snake Toxins: Is the Functional Diversity of Snake Toxins Associated with a Mechanism of Accelerated Evolution?

Very thin strut biodegradable polymer everolimus-eluting and sirolimus-eluting stents versus durable polymer zotarolimus-eluting stents in allcomers with coronary artery disease (BIO-RESORT): a three-arm, randomised, non-inferiority trial

First Report of 3-Year Clinical Outcome After Treatment With Novel Resolute Onyx Stents in the Randomized BIONYX Trial

Thin composite wire strut, durable polymer-coated (Resolute Onyx) versus ultrathin cobalt–chromium strut, bioresorbable polymer-coated (Orsiro) drug-eluting stents in allcomers with coronary artery disease (BIONYX): an international, single-blind, randomised non-inferiority trial

Thin Composite-Wire-Strut Zotarolimus-Eluting Stents Versus Ultrathin-Strut Sirolimus-Eluting Stents in BIONYX at 2 Years

Thin, Very Thin, or Ultrathin Strut Biodegradable or Durable Polymer-Coated Drug-Eluting Stents

Prediabetes and its impact on clinical outcome after coronary intervention in a broad patient population

Thin, Very Thin, or Ultrathin Strut Biodegradable or Durable Polymer-Coated Drug-Eluting Stents: 3-Year Outcomes of BIO-RESORT

Impact of prediabetes and diabetes on 3-year outcome of patients treated with new-generation drug-eluting stents in two large-scale randomized clinical trials

Third-generation zotarolimus-eluting and everolimus-eluting stents in all-comer patients requiring a percutaneous coronary intervention (DUTCH PEERS): a randomised, single-blind, multicentre, non-inferiority trial

Outcome after percutaneous coronary intervention with contemporary stents in patients with concomitant peripheral arterial disease: A patient-level pooled analysis of four randomized trials

Final 5‐year report of BIONYX comparing the thin‐composite wire‐strut zotarolimus‐eluting stent versus ultrathin‐strut sirolimus‐eluting stent

Small-vessel treatment with contemporary newer-generation drug-eluting coronary stents in all-comers: Insights from 2-year DUTCH PEERS (TWENTE II) randomized trial

Final 5-Year Report of the Randomized BIO-RESORT Trial Comparing 3 Contemporary Drug-Eluting Stents in All-Comers

Risk of bleeding after percutaneous coronary intervention and its impact on further adverse events in clinical trial participants with comorbid peripheral arterial disease

Two-year clinical outcome of all-comers treated with three highly dissimilar contemporary coronary drug-eluting stents in the randomised BIO-RESORT trial

TCT-518 Final 5-Year Report of the Randomized BIONYX Trial Assessing Onyx Versus Orsiro Drug-eluting Stents in All-Comers

Two-year outcome after treatment of severely calcified lesions with newer-generation drug-eluting stents in acute coronary syndromes: A patient-level pooled analysis from TWENTE and DUTCH PEERS

5-Year Outcome Following Randomized Treatment of All-Comers With Zotarolimus-Eluting Resolute Integrity and Everolimus-Eluting PROMUS Element Coronary Stents: Final Report of the DUTCH PEERS (TWENTE II) Trial

Three contemporary thin‐strut drug‐eluting stents implanted in severely calcified coronary lesions of participants in a randomized all‐comers trial

Suchergebnisse filtern